Defense against chemical warfare agents and toxic industrial chemicals (TICS)

Proceedings - Department of Defense High Performance Computing Modernization Program Users Group Conference, UGC 2004

Volumn , Issue , 2004, Pages 20-26

  Hurley, Margaret M ^a   Balboa, Alex ^b   Wright, Jeffrey B ^c   Lushington, Gerald H ^d   Guo, Jianxin ^d  

^a U S ARMY RESEARCH LABORATORY   (United States)

^b EDGEWOOD CHEMICAL BIOLOGICAL CENTER   (United States)

^c US Army Soldier and Biological Chemical Command (SBCCOM)   (United States)

^d UNIVERSITY OF KANSAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINESTERASE (ACHE); PROPHYLAXIS; QUANTITATIVE STRUCTURE ACTIVITY RELATIONSHIPS (QSAR); TOXICOLOGY;

BROMINE COMPOUNDS; CHEMICAL WARFARE; DRUG PRODUCTS; HEALTH RISKS; HYDROGEN BONDS; NEUROPHYSIOLOGY; PHOSPHORUS COMPOUNDS; THERMODYNAMICS; TOXIC MATERIALS;

INDUSTRIAL CHEMICALS;

EID: 21444456937     PISSN: None     EISSN: None     Source Type: Conference Proceeding    
DOI: None     Document Type: Conference Paper

References (15)

1. Golomb B.A., "A review of the scientific literature as it pertains to Gulf War illnesses." RAND Report to the Special Assistant to the Deputy Secretary of Defense for Gulf War Illnesses, Volume 2: Pyridostigmine Bromide, 1999; MR1018/2-OSD: available online at http://www.rand.Org/publications/MR/MR1018.2/
2. Zhou, H-X, S.T. Wlodek, and J.A. McCammon, "Conformation gating as a mechanism for enzyme specificity." Proc. Nat. Acad. Sci. USA, 95, 1998, pp. 9280-9283.
3. Kryger, G., M. Harel, K. Giles, L. Toker, B. Velan, A., Lazar, C. Kronman, D. Barak, N. Ariel, A. Shafferman, I. Silman, and J.L. Sussman, "Structure of Recombinant Native and E202Q Mutant Human Acetylcholmesterase Complexed with the Snake-Venom Toxin Fasciculin-II." Acta Crystallogr., Sect. D 56, 2000, pp. 1385-1394.
4. Kryger, G., I. Silman, and J.L. Sussman, "Structure of Acetylcholinesterase Complexed with E2020 (Aricept): Implications for the Design of New Anti-Alzheimers Drugs." Structure, 7, 1999, pp. 297-307.
5. Sybyl/Unity 6.9., Nov 2002, Tripos, Inc.
6. Molecular Operating Environment (MOE) 2002.03, Chemical Computing Group Inc., Mar 2002.
7. Palin, R., J.K. Clark, P. Cowley, A.W. Muir, E. Pow, A.B. Prosser, R. Taylor, and M-Q. Zhang, "Novel Piperidinium and Pyridinium Agents as Water-Soluble Acetylcholinesterase Inhibitors for the Reversal of Neutomuscular Blockade." Bioorg. Med. Chem. Lett., 12, 2002, pp. 2569-2572.
8. Villalobos, A., J.F. Blake, C.K. Biggers, T.W. Butler, D.S. Chapin, Y.L. Chen, J.L. Ives, S.B. Jones, D.R. Liston, A.A. Nagel, D.M. Nason, J.A. Nielsen, I.A. Shalaby, and W.F. White, "Novel Bcnzisoxazole Derivatives as Potent and Selective Inhibitors of Acetylcholinesterase." J. Med. Chem., 37, 1994, pp. 2721-2734.
9. Clark, J.K, P. Cowley, A.W. Muir, R. Palin, E. Pow, A.B. Prosser, R. Taylor, and M.-Q. Zhang, "Quaternary Salts of E2020 Analogues as Acetylchoinesterase Inhibitors for the Reversal of Neuromuscular Block." Bioorg. Med. Chem. Lett., 12, 2002, pp. 2565-2568.
10. Jones, G., P. Willett, R. Glen, A.R. Leach, and R. Taylor, "Development and Validation of a Genetic Algorithm for Flexible Docking." J. Mol. Biol., 267, 1997, pp. 727-748.
11. SIMCA-P, July 2001, Umereics AB.
12. Case, D.A., D.A. Pearlman, J.W. Caldwell, T.E. Cheatam, III, J. Wang, W.S. Ross, C.L. Simmerling, T.A. Darden, K.M. Merz, R.V. Stanton, A.L. Cheng, J.J. Vinvent, M. Crowley, J. Tsui, H. Gohlke, R.J. Radmer, Y. Duan, J. Pitera, I. Massova, G.L. Seibel, U.C. Singh, P.K. Weiner, and P.A. Kollman, "AMBER 6.", University of California, San Francisco, CA.
13. Gaussian 03. Revision B05, M.J. Frisch, G.W. Trucks, H.B. Schlegel, G.E. Scuseria, M.A. ; Robb, J.R. Cheeseman, J.A. Montgomery, Jr.,T. Vreven, K.N. Kudin,J.C. Burant, J.M. Millam, S.S. Iyengar, J. Tomasi,V. Barone, B. Mennucci, M. Cossi, G. Scalmani, N. Rega, G.A. Petersson, H. Nakatsuji, M. Hada, M. Ehara, K. Toyota, R. Fukuda, J. Hasegawa, M. Ishida, T. Nakajima, Y. Honda, O. Kitao, H. Nakai, M. Klene, X. Li, J.E. Knox, H.P. Hratchian, J.B. Cross, C. Adamo, J. Jaramillo, R. Gomperts, R.E. Stratmann, O. Yazyev, A.J. Austin, R. Cammi, C. Pomelli, J.W. Ochterski, P.Y. Ayala, K. Morokuma, G.A. Voth, P. Salvador, J.J. Dannenberg, V.G. Zakrzewski, S. Dapprich, A.D. Daniels, M.C. Strain, O. Farkas, D.K. Malick, A.D. Rabuck, K. Raghavachari, J.B.; Foresman, J.V. Ortiz, Q. Cui, A.G. Baboul, S. Clifford, J. Cioslowski,B-B. Stefanov, G.; Liu, A. Liashenko, P. Piskorz, I. Komaromi, R.L. Martin, D.J. Fox, T. Keith, M.A. Al-Laham, C.Y. Peng, A.; Nanayakkara, M. Challacombe, M.; P.M.W. Gill, B. Johnson, W. Chen, M.W. Wong, C. Gonzalez, and J.A. Pople, Gaussian, Inc., Pittsburgh, PA, 2003.
14. Shen T.Y., K.H. Tai, R.H. Henchman, and A.J. McCammon, "Molecular dynamics of acetylcholinesterase." Accts. Chem. Res., 2002; 35, 2002, pp. 332-340.
15. Massiah, M.A., C. Viragh, P.M. Reddy, I.M. Kovach, J. Johnson, T.L. Rosenberry. and A.S- Mildvan, "Short, Strong Hydrogen Bonds at the Active Site of Human Acetylcholinesterase: Proton NMR Studies.", Biochemistry, 40, 2001, pp.5682-5690 and references therein.